Day: May 28, 2025

CurifyLabs secures €6.7M to launch RoboPharma and redefine drug supply resilience

CurifyLabs secures €6.7M to launch RoboPharma and redefine drug supply resilience Finnish healthtech company CurifyLabs has raised €6.7 million to modernise and automate the manufacturing of compounded medications, making them safer and better suited for the specific, individual needs of patients. This raise brings its funding to  €17.6 million. Compounded

SpAItial emerges from stealth with $13M Seed for AI-native 3D applications

SpAItial emerges from stealth with $13M Seed for AI-native 3D applications AI startup SpAItial has emerged from stealth mode with a $13 million seed round led by Earlybird Venture Capital, joined by Speedinvest and several high-profile angels. SpAItial is building physics-consistent, spatio-temporally grounded AI that understands the 3D world like

Innovation without borders: The growth of the Western Balkan startup landscape

Innovation without borders: The growth of the Western Balkan startup landscape Monitoring the technological ecosystem in Europe, much like in other sectors, reveals a significant development gap between major technological powers and smaller, less developed countries. These countries are making active efforts to leverage their unique advantages (such as compact

Lithuania’s Genomika joins €5.2M DiDAX Project to advance DNA data storage

Lithuania’s Genomika joins €5.2M DiDAX Project to advance DNA data storage Lithuanian biotech firm Genomika has joined the DiDAX project, contributing €600,000 to a total project budget of €5.2 million.  Unlike conventional methods, DNA-based storage is designed for secure, long-term data preservation. Its stability can be measured in centuries or

Volare raises €26M to advance sustainable insect protein production

Volare raises €26M to advance sustainable insect protein production Finnish biotech company Volare has closed a €26 million funding round to build protein production plant Volare 01 and to advance its unique technology.  Volare turns food industry side streams into sustainable insect protein, oil and fertilisers on an industrial scale. 

Hormona, a HealthTech startup enabling women to track, understand and optimise their hormones, raises €7.8 million

Hormona, a HealthTech startup enabling women to track, understand and optimise their hormones, raises €7.8 million London-based Hormona, a HealthTech company using AI and at-home testing to help women track, understand and optimise their hormones, has raised a €7.8 million Seed round to fuel their expansion and help launch its

Finnish HealthTech startup CurifyLabs raises €6.7 million to make medicine safer and more personalised

Finnish HealthTech startup CurifyLabs raises €6.7 million to make medicine safer and more personalised Helsinki-based CurifyLabs, a HealthTech company, has raised €6.7 million to moderniwe and automate the manufacturing of compounded medications, aiming to make them safer and better suited for the specific, individual needs of patients. The funding round

Finnish MedTech startup Surgify Medical raises €7 million to make bone surgery safer with tissue-selective technology

Finnish MedTech startup Surgify Medical raises €7 million to make bone surgery safer with tissue-selective technology Surgify Medical, an Espoo-based MedTech company focused on improving the safety and precision of bone surgery with its Surgify Halo technology, has successfully raised €7 million in Series A funding. The funding round was

From video games to urban planning – British SpAItial emerges from stealth with €11.4 million to develop their 3D modelling AI

From video games to urban planning – British SpAItial emerges from stealth with €11.4 million to develop their 3D modelling AI London-based SpAItial, a startup focused on how AI understands and generates 3D environments, has emerged from stealth mode with a €11.4 million Seed round in order to scale the

Swiss BioTech Hedera Dx has just bagged €15 million to bring modern cancer care to patients across the globe

Swiss BioTech Hedera Dx has just bagged €15 million to bring modern cancer care to patients across the globe Lausanne-based Hedera Dx, a BioTech company, today announced the closing of a €15 million Series A financing round to drive advanced cancer care and overcome structural barriers that prevent cancer patients